v3.26.1
Interim Condensed Consolidated Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Issued and additional paid in capital [member]
Transaction with non-controlling interest [member]
Foreign currency translation [member]
Retained earnings [member]
Equity attributable to owners of parent [member]
Non-controlling interests [member]
Total
Beginning balance, value at Dec. 31, 2022 $ 32,713   $ (537) $ (30,020) $ 2,156 $ 2,156
IfrsStatementLineItems [Line Items]              
Net loss   (20,914) (20,914) (75) (20,989)
Other comprehensive loss   46 46 17 63
Total comprehensive loss   46 (20,914) (20,868) (58) (20,926)
Share-based compensation 3,269   3,269 3,269
Conversion of convertible notes into ordinary shares 5,955   5,955 5,955
Issuance of ordinary shares -SEPA facility fee 4,896   4,896 4,896
Recapitalization due to issuance of ordinary shares following the SPAC transaction, net 11,460   11,460 11,460
Exercise of options into ordinary shares 10   10 10
Issuance of ordinary shares and warrants B, net 1,837   1,837 1,837
Conversion of warrants A into ordinary shares 1,008   1,008 1,008
Exercise of warrants B into ordinary shares, net 888   888 888
Issuance of warrants B after reset 865   865 865
Non-controlling interests arising from initially consolidated companies   20,826 20,826
Ending balance, value at Dec. 31, 2023 62,901 (491) (50,934) 11,476 20,768 32,244
IfrsStatementLineItems [Line Items]              
Net loss (31,092) (31,092) (4,309) (35,401)
Other comprehensive loss (1,306) (1,306) 41 (1,265)
Total comprehensive loss (1,306) (31,092) (32,398) (4,268) (36,666)
Share-based compensation 3,657 3,657 3,657
Conversion of convertible notes into ordinary shares 7,529 7,529 7,529
Issuance of ordinary shares -SEPA facility fee 1,684 1,684 1,684
Conversion of bridge loan into ordinary shares and warrants 128 128 128
Conversion of convertible notes into ordinary shares 527 527 527
Issuance of investment units 2,699 2,699 2,699
Exercise of warrants and options into ordinary shares, net 10,590 10,590 10,590
Transaction with non-controlling interests 261 258 519 (519)
Ending balance, value at Dec. 31, 2024 89,976 258 (1,797) (82,026) 6,411 15,981 22,392
IfrsStatementLineItems [Line Items]              
Net loss (169,178) (169,178) (5,412) (174,590)
Other comprehensive loss (3,030) (3,030) (100) (3,130)
Total comprehensive loss (3,030) (169,178) (172,208) (5,512) (177,720)
Share-based compensation 114,205 114,205 114,205
Conversion of convertible notes into ordinary shares 43,146 43,146 43,146
Conversion of short term loan into ordinary shares 4,134 4,134 4,134
Equity issuance to investors 10,529 10,529 10,529
Issuance of ordinary shares -SEPA facility fee 2,639 2,639 2,639
Ending balance, value at Dec. 31, 2025 264,629 258 (4,827) (251,204) 8,856 10,469 19,325
IfrsStatementLineItems [Line Items]              
Net loss   (44,348) (44,348) (1,102) (45,450)
Other comprehensive loss (3,156) (3,156) (10) (3,166)
Total comprehensive loss   (3,156) (44,348) (47,504) (1,112) (48,616)
Share-based compensation 9,022 9,022 9,022
Equity issuance to investors 465 465 465
Issuance of ordinary shares -SEPA facility fee 911 911 911
Conversion of convertible notes into ordinary shares 11,080 11,080 11,080
Issuance of Ordinary shares due to SEPA withdrawals 62,167 62,167 62,167
Ending balance, value at Jun. 30, 2026 $ 348,274 $ 258 $ (7,983) $ (295,552) $ 44,997 $ 9,357 $ 54,354